Your browser doesn't support javascript.
loading
NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models.
Gruijs, Mandy; Ganzevles, Sonja H; Stigter-van Walsum, Marijke; van der Mast, Richard; van Ostaijen-Ten Dam, Monique M; Tuk, Cornelis W; Schilham, Marco W; Leemans, C René; Brakenhoff, Ruud H; van Egmond, Marjolein; van de Ven, Rieneke; Bakema, Jantine E.
Afiliación
  • Gruijs M; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • Ganzevles SH; Amsterdam UMC, Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • Stigter-van Walsum M; Amsterdam UMC, Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • van der Mast R; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • van Ostaijen-Ten Dam MM; Amsterdam UMC, Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • Tuk CW; Leiden University Medical Center, Department of Pediatrics, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
  • Schilham MW; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • Leemans CR; Leiden University Medical Center, Department of Pediatrics, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
  • Brakenhoff RH; Amsterdam UMC, Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • van Egmond M; Amsterdam UMC, Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • van de Ven R; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • Bakema JE; Amsterdam UMC, Department of Surgery, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Int J Mol Sci ; 22(20)2021 Oct 14.
Article en En | MEDLINE | ID: mdl-34681717
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Receptor Toll-Like 2 / Neoplasias de Cabeza y Cuello / Citotoxicidad Celular Dependiente de Anticuerpos Límite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Receptor Toll-Like 2 / Neoplasias de Cabeza y Cuello / Citotoxicidad Celular Dependiente de Anticuerpos Límite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos